Healthpeak Properties, Inc. (NYSE:DOC) continues to attract interest from various investment firms with
Twinbeech Capital LP,
ProShare Advisors LLC,
Toronto Dominion Bank,
Nomura Holdings Inc. and
Systematic Financial Management LP increasing their positions. This comes after the declaration of
Second Quarter 2025 common stock cash dividends, posting a 7%
NOI growth, and naming
Kelvin Moses as CFO. Furthermore, its Q4 2024 results showed an increase in cash dividends. Healthpeak also reported strong Q1 2025 results with
EPS at $0.06 and Revenue hitting $702.9 Million. Despite Scotiabank reducing the price target and the announcement of a partnership with
Hines on the Cambridge Point Mixed-Use Development, the stock still outperforms in the real estate sector.
CEO Scott Brinker also purchased $200,438 worth of stock, underlining strong financial synergies post the Physicians Realty merger. With these developments, Healthpeak is considered a good dividend stock and a smart buy for income investors.
Healthpeak Properties DOC News Analytics from Mon, 23 Sep 2024 07:00:00 GMT to Sat, 24 May 2025 23:46:33 GMT -
Rating 8
- Innovation 5
- Information 6
- Rumor -2
